Reported about 7 hours ago
Private equity firm GTCR has finalized a $4.8 billion deal to acquire Czech generic drugmaker Zentiva from Advent International, as reported by the Financial Times. Advent previously purchased Zentiva from Sanofi in 2018 for €1.9 billion. Zentiva operates in over 30 countries and employs more than 5,000 people.
Source: YAHOO